Genomic Testing Cooperative, LCA (GTC) announced that it will be presenting at the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting three studies illustrating the power of its proprietary RNA next generation sequencing (NGS) approach in advancing liquid biopsy and tissue-based precision testing. In one study GTC and its co-op members demonstrate that its targeted transcriptome analysis when used with artificial intelligence (AI) algorithm can distinguish between mutations caused by cancer versus those caused by...